Skip to content

Evaluation of Contact Lenses and Myopia.

Myopia Prevention Study in Chinese Population With Dual Focus Myopia Control Lenses.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07566234
Enrollment
110
Registered
2026-05-05
Start date
2026-06-06
Completion date
2029-05-01
Last updated
2026-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pre-myopia

Brief summary

This study will evaluate the effect of dual focus contact lenses on Myopia prevention.

Interventions

DEVICETest Lens - Dual Focus

Dual-Focus Contact Lens

Sponsors

CooperVision International Limited (CVIL)
Lead SponsorINDUSTRY
Shanghai Eye Disease Prevention and Treatment Center
CollaboratorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
8 Years to 10 Years
Healthy volunteers
No

Inclusion criteria

1. Male and female children aged between 8-10 years inclusive. 2. Cycloplegic SER from -0.25 (non-inclusive) to +0.75 D (inclusive) in both eyes. 3. Astigmatism ≤ -1.00D in both eyes. 4. Un-corrected visual acuity (UCVA) ≤ 0.1 LogMAR. 5. As applicable (dependent on local requirements), the subject and parent/legal guardian will have read the Informed Assent/Consent, been given an explanation of the study, indicated an understanding and signed the forms. 6. Along with their parent or guardian, be capable of comprehending the nature of the study, and be willing and able to adhere to the instructions set forth in this protocol. 7. Along with their parent or guardian, agree to maintain the visit schedule and be able to keep all appointments as specified in the study protocol for the duration of the study. 8. Agree and able to wear the assigned contact lenses successfully for a minimum of 10 hours per day, at least 6 days per week, for the duration of the study and to inform the study investigator if this schedule is interrupted. (Wearing time may be modified by the study staff for health reasons.) 9. Be in good general health, based on his/her and parent's/guardian's knowledge. 10. Any history of myopia control interventions with in 1 month must complete a 4-weeks of washout period.

Exclusion criteria

1. History of myopia control intervention (e.g., atropine, orthokeratology, soft myopia control contact lenses, red light therapy, etc. over more than 1 month) 2. Currently wears rigid gas permeable contact lenses, including orthokeratology lenses. 3. Current use of systemic or ocular or medications which may affect contact lens wear, tear film production, pupil size, accommodation or refractive state. 4. Ocular or systemic disease that contraindicates contact lens wear. 5. Active allergic conjunctivitis. 6. Any ocular, systemic or neuro-developmental conditions that could influence refractive development. 7. Keratoconus or an irregular cornea. 8. History of clinically significant binocular vision abnormality or strabismus. 9. Any active anterior segment finding that would contraindicate contact lens wear. 10. The investigator for any reason considers that it is not in the best interest of the subject to participate in the study.

Design outcomes

Primary

MeasureTime frame
Myopia onset (cycloplegic SER ≤ -0.50D) in either or both eyes at 2 years.Through study completion, 2 years.

Countries

China

Contacts

CONTACTBaskar Arumugam Sr. Research Lead, PhD
barumugam@coopervision.com925-353-8468
PRINCIPAL_INVESTIGATORXiangui He, PhD

Shanghai Eye Disease Prevention and Treatment Center

PRINCIPAL_INVESTIGATORMengjun Zhu

Shanghai Eye Disease Prevention and Treatment Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 17, 2026